X4 Pharmaceuticals, Inc. (XFOR)
4.04
0.00 (0.00%)
USD |
NASDAQ |
Aug 31, 16:00
4.05
+0.01
(+0.25%)
After-Hours: 20:00
X4 Pharmaceuticals Cash from Operations (Annual) : -85.62M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -85.62M |
| December 31, 2024 | -130.90M |
| December 31, 2023 | -96.51M |
| December 31, 2022 | -77.10M |
| December 31, 2021 | -70.90M |
| December 31, 2020 | -58.82M |
| Date | Value |
|---|---|
| December 31, 2019 | -48.06M |
| December 31, 2018 | -25.42M |
| December 31, 2017 | -27.87M |
| December 31, 2016 | -21.64M |
| December 31, 2015 | -10.82M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Sarepta Therapeutics, Inc. | -222.54M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |
| Sangamo Therapeutics, Inc. | -97.21M |
| Anixa Biosciences, Inc. | -7.173M |